| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |